Search clinical trials for: ADVAIR DISKUS® 250/50

Total 927 results

Pfizer

Completed

A Target Occupancy Study With Ritlecitinib.

Healthy

United States
Celgene

Completed

Safety and Pharmacokinetics of AVL-292 Following Multiple Doses and the Effect of Food on the Single-dose Pharmacokinetics of AVL-292

Healthy

United States
Respirent Pharmaceuticals Co Ltd.
Becro Ltd.

Recruiting

Bioequivalence With Clinical Endpoint Study of Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma (AERO-PD)

Asthma

Greece
Mylan Pharmaceuticals Inc

Completed

A Comparison of Mometasone Nasal Spray, Nasonex Nasal Spray, Nasonex Nasal Spray Suspension, & Placebo for Treatment of Seasonal Allergies for Safety, Efficacy, & Superiority in 1520 Male & Female Volunteers

Treatment of the Signs and Symptoms of Seasonal Allergic Rhinitis
Respirent Pharmaceuticals Co Ltd.
Becro Ltd.

Completed

A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. SERETIDE DISKUS® in Healthy Volunteers With Charcoal Blockade (BREATH-PK250-CC)

Bioequivalence

Greece
Reseach Laboratory of Clinical and Experimental...
Société Arabe des Industries Pharmaceutiques SAIPH - Tunisia; Centre National...

Completed

Bioequivalence Study to Compare Metformin / Vildagliptin (850 mg/50 mg) Versus Galvumet®

Fed Conditions

Tunisia
GlaxoSmithKline

Completed

Fall Epidemic Viral Pediatric Study

Asthma

United States
Novartis Pharmaceuticals

Recruiting

A 24-week rPMS Study in Real-world Setting for Enerzair

Asthma

Korea, Republic of
Boehringer Ingelheim

Completed

Salmeterol Inhalation Powder Administered as the Xinafoate Salt From Hard Polyethylene Capsules Via the HandiHaler® 2, and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive
University of Manitoba
innoVactiv Inc.

Completed

Efficacy of a Brown Seaweed Powder for Glycemic Control

Blood Glucose

Canada
Respirent Pharmaceuticals Co Ltd.
Becro Ltd.

Active, not recruiting

Bioequivalence Study for Fluticasone Propionate 100 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers

Bioequivalence

Greece
Cipla Ltd.

Completed

BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients

Bronchial Asthma

United States
GlaxoSmithKline

Completed

WEUSKOP6416: Evaluating Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) Subjects

Pulmonary Disease, Chronic Obstructive
Johnson & Johnson Vision Care, Inc.

Completed

Pilot Evaluation of a New Galyfilcon A Lens Prototype and Enfilcon A Lens

Myopia

United States
Ache Laboratorios Farmaceuticos S.A.

Terminated

Study to Assess Tolerability, Safety and Pharmacokinetics of a New Drug (ACH15)

Healthy

Brazil
Alebund Pty Ltd

Completed

A Safety, Tolerability, and Pharmacokinetics Study of AP303 in Healthy Subjects

Healthy Subjects

Australia
DBV Technologies
Todd D. Green MD, DBV Technologies

Available

Expanded Access Protocol of Viaskin® Peanut (DBV712) in Peanut-allergic Children

Peanut Allergy

United States
AstraZeneca

Completed

Symbicort Onset of Action 1

Asthma
Novo Nordisk A/S

Completed

Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Months

Diabetes Mellitus, Type 2 | Diabetes

Slovenia
Takeda

Completed

Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine in Children

Norovirus

Finland, Panama, Colombia
Respirent Pharmaceuticals Co Ltd.
Becro Ltd.

Completed

A Bioequivalence Study Between Fluticasone and Salmeterol vs. SERETIDE DISKUS® in Healthy Volunteers With Charcoal Blockade

Bioequivalence

Greece
Memorial Sloan Kettering Cancer Center

Active, not recruiting

A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer

Small Cell Lung Carcinoma | Small-cell Lung Cancer

United States
Respirent Pharmaceuticals Co Ltd.
Becro Ltd.

Completed

A Bioequivalence Study Between Fluticasone Propionate 100 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 Inhalation Powder/GSK in Healthy Volunteers

Bioequivalence

Greece
Novo Nordisk A/S

Completed

Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects

Congenital Bleeding Disorder | Haemophilia A

Spain, Germany, Switzerland, Italy, Israel
GlaxoSmithKline

Completed

A Four-way Crossover, Single and Repeat Dose Study to Determine the Dose Proportionality and Absolute Bioavailability of Fluticasone Furoate Inhalation Powder Administered by Novel Dry Powder Inhaler (NDPI)

Asthma

Netherlands
Roxane Laboratories
Vectura Limited

Completed

Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate

Asthma

United States
Derming SRL

Completed

Aesthetic Performance of an Intradermal Injection Treatment for Face Photoaging: Interstitial or Cushion Technique in Comparison to Bolus Technique at Five Points (Half - Face Method Within Subjects)

Face Photoaging

Italy
GlaxoSmithKline

Completed

The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastroparesis

Gastroparesis

Belgium, Sweden
Eisai Co., Ltd.

Completed

A Double-Blind Study of E5555 in Japanese Subjects With Coronary Artery Disease

Coronary Artery Disease

Japan
Military University Hospital, Prague

Recruiting

Adjustable Gravitational vs. Adjustable Differential Pressure Valves in iNPH

Normal Pressure Hydrocephalus

Czechia
Valley Medical Research

Completed

The Effect on Depressive Symptoms in ECF Residents With COPD (DISK-02)

Depression | Chronic Obstructive Pulmonary Disease

United States
National Institute of Diabetes and Digestive and...

Recruiting

The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure

Obesity | Healthy Volunteers | Normal Physiology

United States
AstraZeneca

Completed

The Study Will Evaluate the Effect of AZD8683 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Poland
Centre d'Investigation Clinique et Technologique...
Adep Assistance

Completed

Instrumental and Manual Increase of Couch in Neuromuscular Patients (OPTICOUGH)

Chronic Respiratory Failure | Neuromuscular Disease | Coughing

France
University Hospital, Bordeaux

Withdrawn

Description of the Ability to Learn How to Handle Inhaler Devices in Asthma (AUDIT)

Asthma

France
GlaxoSmithKline

Completed

Treatment Of Partial Reversible Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive

Netherlands
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy Study of MK0974 in the Acute Migraine (0974-016)

Migraine
Galapagos NV

Completed

Multiple Ascending Dose Study of GLPG0634 in Japanese and Caucasian Healthy Subjects

Healthy

United Kingdom
Pfizer

Recruiting

Safety and Efficacy of Xalkori ROS1

Non-small Cell Lung Cancer

Japan
Mutual Pharmaceutical Company, Inc.

Completed

Fasted Bioequivalence Study of Primidone Tablets and Mysoline Tablets

Therapeutic Equivalency
Johns Hopkins All Children's Hospital

Terminated

Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors

Central Nervous System Tumors

United States
Alcon Research

Enrolling by invitation

EX-PRESS® P-50 and EX-PRESS® P-200

Glaucoma

United States
GlaxoSmithKline

Completed

A Study to Assess the Efficacy of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Germany, Romania, Russian Federation, United States, Ukraine
Warner Chilcott

Completed

Treatment of Erectile Dysfunction - Long Term Safety and Efficacy

Erectile Dysfunction

United States
JLLC NatiVita
National Anti Doping Laboratory, Belarus

Not yet recruiting

The Bioequivalence Study of Two Sunitinib Products in Capsules 50 mg in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Belarus
Jena University Hospital

Active, not recruiting

Pentaerithrityl Tetranitrate (PETN) for Secondary Prevention of Intrauterine Growth Restriction (PETN)

Pregnancy Related | Fetal Growth Retardation | Intrauterine Growth Restriction

Germany
Università degli Studi di Sassari

Completed

SINUS LIFT 100% Anorganic Bovine Bone vs. 50% Anorganic Bovine Bone + 50% Autologous Bone

Dental Implants | Maxillary Sinus

Italy
GlaxoSmithKline

Completed

Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies.

Pulmonary Disease, Chronic Obstructive

United States
Pfizer

Completed

Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan)

Non-small Cell Lung Cancer
Amneal Ireland Limited

Unknown

A Study to Compare Fluticasone Propionate 100mcg/Salmeterol 50 mcg Inhalation Powder to Advair Discus 100/50

Asthma

3

Subscribe